Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie E Combs

Showing results (321-330 of 567) with videos related to

Pageof 57
Sort By:
Cells|March 27, 2026
Differential Cytokine and DNA Damage Response of Human Lung Tissue Models to Broad-Beam and Microbeam RadiotherapyAleksandra Čolić, Marina Santiago Franco, Narayani Subramanian, et al.
Frontiers in Oncology|April 1, 2024
Single brain metastases - prognostic factors and impact of residual tumor burden on overall survivalLea Baumgart, Aida Anetsberger, Amir Kaywan Aftahy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2022
nTMS-derived DTI-based motor fiber tracking in radiotherapy treatment planning of high-grade gliomas for avoidance of motor structuresChristian D Diehl, Enrike Rosenkranz, Martin Mißlbeck, et al.
BMC Cancer|October 8, 2010
Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trialStephanie E Combs, Iris Burkholder, Lutz Edler, et al.
Plos One|August 21, 2019
Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastomaFriederike Lämmer, Claire Delbridge, Silvia Würstle, et al.
Plos One|March 11, 2021
Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastomaFriederike Lämmer, Claire Delbridge, Silvia Würstle, et al.
Frontiers in Oncology|April 21, 2023
Brain metastases in the elderly - Impact of residual tumor volume on overall survivalLea Baumgart, Amir Kaywan Aftahy, Aida Anetsberger, et al.
Radiation Oncology (London, England)|November 8, 2017
First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomasJan Oliver Dittmar, Clemens Kratochwil, Anne Dittmar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
Detecting Metastatic Patterns of Oligometastatic Breast Cancer: A Comparative Analysis of <sup>18</sup>F-FDG PET/CT and Conventional CT ImagingRebecca Moser, Sophie Pfeiffer, Lisena Cala, et al.
Expert Review of Molecular Diagnostics|April 4, 2026
What is the future of nanoparticles as a clinical theranostic tool for glioblastoma?Maxim Shevtsov, Viacheslav Fedorov, Natalia Yudintceva, et al.
Pageof 57

Showing results (321-330 of 567) with videos related to

Sort By:
Pageof 57
Cells|March 27, 2026
Differential Cytokine and DNA Damage Response of Human Lung Tissue Models to Broad-Beam and Microbeam RadiotherapyAleksandra Čolić, Marina Santiago Franco, Narayani Subramanian, et al.
Frontiers in Oncology|April 1, 2024
Single brain metastases - prognostic factors and impact of residual tumor burden on overall survivalLea Baumgart, Aida Anetsberger, Amir Kaywan Aftahy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2022
nTMS-derived DTI-based motor fiber tracking in radiotherapy treatment planning of high-grade gliomas for avoidance of motor structuresChristian D Diehl, Enrike Rosenkranz, Martin Mißlbeck, et al.
BMC Cancer|October 8, 2010
Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trialStephanie E Combs, Iris Burkholder, Lutz Edler, et al.
Plos One|August 21, 2019
Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastomaFriederike Lämmer, Claire Delbridge, Silvia Würstle, et al.
Plos One|March 11, 2021
Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastomaFriederike Lämmer, Claire Delbridge, Silvia Würstle, et al.
Frontiers in Oncology|April 21, 2023
Brain metastases in the elderly - Impact of residual tumor volume on overall survivalLea Baumgart, Amir Kaywan Aftahy, Aida Anetsberger, et al.
Radiation Oncology (London, England)|November 8, 2017
First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomasJan Oliver Dittmar, Clemens Kratochwil, Anne Dittmar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
Detecting Metastatic Patterns of Oligometastatic Breast Cancer: A Comparative Analysis of <sup>18</sup>F-FDG PET/CT and Conventional CT ImagingRebecca Moser, Sophie Pfeiffer, Lisena Cala, et al.
Expert Review of Molecular Diagnostics|April 4, 2026
What is the future of nanoparticles as a clinical theranostic tool for glioblastoma?Maxim Shevtsov, Viacheslav Fedorov, Natalia Yudintceva, et al.
Pageof 57